About this trial
The aortic valve bicuspidia (BVA) is a congenital condition corresponding to the presence of 2 sigmoids instead of 3. This is the most common cardiac congenital anomaly affecting 0.5 to 2% of the population The general rule. BVA may be associated with structural damage to the ascending aorta, which exposes BVA patients to a risk of developing ascending aortic aneurysm and acute aortic accidents. Recent data from the literature have revealed that the natural history of BVA is marked by a possible development towards significant valvulopathy and / or an ascending aortic aneurysm often requiring surgical treatment. However, the natural history of bicuspid disease remains poorly understood and the prognostic factors for progression to severe valvulopathy and / or aneurysmal dilatation of the ascending aorta remain to be determined.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients examined in the echocardiography laboratory whose objective examination was a bicuspid valve of the aortic valve
Bicuspidia may be formerly known
Disqualifiers
Refusal to participate
Patients who had already undergone bicuspid surgery or ascending aorta before being examined at the echocardiography laboratory
Trial population
Patients with aortic bicuspidia examined in the echocardiography laboratory at one of the participating centers will be systematically eligible to participate in the study
Trial design
Cohort
Prospective
Treatments tested in this trial
Study the natural history of bicuspid
Other interventionStudy the natural history of bicuspid
Treatment groups
Trial outcomes
Primary outcomes
Analysis of 10 year mortality in cardiac surgery in a patient with bicuspid
Analyzing the natural history of Bicuspidia
Sponsors and contacts
Click on the lead sponsor to view all of their trials.